8 Apr 2020
Webinar: Ensuring Continuity in Rare Disease Clinical Trials During the COVID-19 Crisis

Watch Ergomed’s Webinar titled “Ensuring Continuity in Rare Disease Clinical Trials During the COVID-19 Crisis”.

This is a recording of a Webinar that we hosted in April 2020.

Please click HERE to see the recording.

 

In this webinar, Ergomed’s experts share their insights on how they have adapted and are continuing to provide reliable and uninterrupted services for their clients, keeping the patient’s safety and well-being as the central focus

Topics include:

  • Ensuring the oversight of ongoing trials in line with regulatory guidance
  • Starting up new trials during the pandemic
  • Practical and logistical issues and mitigations

Presenters: 

  • Alex Artyomenko MD, Head of Rare Disease and RWE Research
  • Christa van Kan, Strategic Director Rare Diseases
  • Sally Amanuel MBA, Head of Regulatory and Clinical Delivery